Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

Abstract Background Benzodiazepines are a class of medications that are being frequently prescribed in Canada but carry significant risk of harm. There has been increasing clinical interest on the potential “sparing effects” of medical cannabis as one strategy to reduce benzodiazepine use. The objec...

Full description

Bibliographic Details
Main Authors: Cerina Dubois, Heidi Fernandes, Mu Lin, Karen J. B. Martins, Jason R. B. Dyck, Scott W. Klarenbach, Lawrence Richer, Ed Jess, John G. Hanlon, Elaine Hyshka, Dean T. Eurich
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Public Health
Subjects:
Medical cannabis
Benzodiazepine
Diazepam equivalence
Anxiety
Epidemiology
Cohort study
Online Access:https://doi.org/10.1186/s12889-024-18356-6

Internet

https://doi.org/10.1186/s12889-024-18356-6

Similar Items